Abstract

Aminopeptidase A (APA) is a membrane-bound zinc metalloprotease cleaving, in the brain, the N-terminal aspartyl residue of angiotensin II to generate angiotensin III, which exerts a tonic stimulatory effect on the control of blood pressure in hypertensive animals. Using a refined APA structure derived from the human APA crystal structure, we docked the specific and selective APA inhibitor, EC33 in the presence of Ca2+. We report the presence in the S1 subsite of Arg-887 (Arg-878 in mouse APA), the guanidinium moiety of which established an interaction with the electronegative sulfonate group of EC33. Mutagenic replacement of Arg-878 with an alanine or a lysine residue decreased the affinity of the recombinant enzymes for the acidic substrate, α-L-glutamyl-β-naphthylamide, with a slight decrease in substrate hydrolysis velocity either with or without Ca2+. In the absence of Ca2+, the mutations modified the substrate specificity of APA for the acidic substrate, the mutated enzymes hydrolyzing more efficiently basic and neutral substrates, although the addition of Ca2+ partially restored the acidic substrate specificity. The analysis of the 3D models of the Arg-878 mutated APAs revealed a change in the volume of the S1 subsite, which may impair the binding and/or the optimal positioning of the substrate in the active site as well as its hydrolysis. These findings demonstrate the key role of Arg-878 together with Ca2 + in APA substrate specificity for N-terminal acidic amino acid residues by ensuring the optimal positioning of acidic substrates during catalysis.

Highlights

  • Aminopeptidase A (APA; EC 3.4.11.7) is a 160 kDa homodimeric type II Zn2+ membranebound aminopeptidase [1, 2]

  • APA belongs to the monozinc aminopeptidase family, which requires Zn2+ for catalytic activity

  • Arg 878 drives aminopeptidase A substrate specificity acidic amino acids and this is due in part to the presence of Ca2+ in the S1 subsite of the APA active site [22, 35]

Read more

Summary

Introduction

Aminopeptidase A (APA; EC 3.4.11.7) is a 160 kDa homodimeric type II Zn2+ membranebound aminopeptidase [1, 2]. APA cleaves the N-terminal glutamyl or aspartyl residue from peptide substrates such as angiotensin II (AngII) and cholecystokinin-8 and is activated by Ca2+. Arg 878 drives aminopeptidase A substrate specificity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Objectives
Methods
Results

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.